Steven M. Fruchtman
2020
In 2020, Steven M. Fruchtman earned a total compensation of $1M as President and Chief Executive Officer at Onconova Therapeutics.
Compensation breakdown
| Bonus | $266,705 |
|---|---|
| Option Awards | $61,507 |
| Salary | $562,224 |
| Stock Awards | $118,173 |
| Other | $23,214 |
| Total | $1,031,823 |
Fruchtman received $562.2K in salary, accounting for 54% of the total pay in 2020.
Fruchtman also received $266.7K in bonus, $61.5K in option awards, $118.2K in stock awards and $23.2K in other compensation.
Rankings
In 2020, Steven M. Fruchtman's compensation ranked 8,502nd out of 13,090 executives tracked by ExecPay. In other words, Fruchtman earned more than 35.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,502 out of 13,090 | 35th |
Division Manufacturing | 3,616 out of 5,624 | 36th |
Major group Chemicals And Allied Products | 1,462 out of 2,257 | 35th |
Industry group Drugs | 1,273 out of 1,957 | 35th |
Industry Pharmaceutical Preparations | 939 out of 1,462 | 36th |
Source: SEC filing on May 25, 2022.
Fruchtman's colleagues
We found one more compensation record of an executive who worked with Steven M. Fruchtman at Onconova Therapeutics in 2020.
2020
Mark Guerin
Onconova Therapeutics
Chief Financial Officer
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019